These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18513431)

  • 1. poolHiTS: a shifted transversal design based pooling strategy for high-throughput drug screening.
    Kainkaryam RM; Woolf PJ
    BMC Bioinformatics; 2008 May; 9():256. PubMed ID: 18513431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pooling in high-throughput drug screening.
    Kainkaryam RM; Woolf PJ
    Curr Opin Drug Discov Devel; 2009 May; 12(3):339-50. PubMed ID: 19396735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing pooling systems for noisy high-throughput protein-protein interaction experiments using boolean compressed sensing.
    Mourad R; Dawy Z; Morcos F
    IEEE/ACM Trans Comput Biol Bioinform; 2013; 10(6):1478-90. PubMed ID: 24407306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new pooling strategy for high-throughput screening: the Shifted Transversal Design.
    Thierry-Mieg N
    BMC Bioinformatics; 2006 Jan; 7():28. PubMed ID: 16423300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miniaturized microfluidic formats for cell-based high-throughput screening.
    Upadhaya S; Selvaganapathy PR
    Crit Rev Biomed Eng; 2009; 37(3):193-257. PubMed ID: 20402621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized high-throughput evaluation of cell-based compound screens.
    Frommolt P; Thomas RK
    BMC Bioinformatics; 2008 Nov; 9():475. PubMed ID: 19014471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategic pooling of compounds for high-throughput screening.
    Hann M; Hudson B; Lewell X; Lifely R; Miller L; Ramsden N
    J Chem Inf Comput Sci; 1999; 39(5):897-902. PubMed ID: 10529988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An efficient method for the detection and elimination of systematic error in high-throughput screening.
    Makarenkov V; Zentilli P; Kevorkov D; Gagarin A; Malo N; Nadon R
    Bioinformatics; 2007 Jul; 23(13):1648-57. PubMed ID: 17463024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic cell culture systems for drug research.
    Wu MH; Huang SB; Lee GB
    Lab Chip; 2010 Apr; 10(8):939-56. PubMed ID: 20358102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shifted Transversal Design smart-pooling for high coverage interactome mapping.
    Xin X; Rual JF; Hirozane-Kishikawa T; Hill DE; Vidal M; Boone C; Thierry-Mieg N
    Genome Res; 2009 Jul; 19(7):1262-9. PubMed ID: 19447967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-content, high-throughput screening for the identification of cytotoxic compounds based on cell morphology and cell proliferation markers.
    Martin HL; Adams M; Higgins J; Bond J; Morrison EE; Bell SM; Warriner S; Nelson A; Tomlinson DC
    PLoS One; 2014; 9(2):e88338. PubMed ID: 24505478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretation of uniform-well readouts.
    Josiah S
    Methods Mol Biol; 2009; 486():177-92. PubMed ID: 19347624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Just-in-Time Compound Pooling Increases Primary Screening Capacity without Compromising Screening Quality.
    Elkin LL; Harden DG; Saldanha S; Ferguson H; Cheney DL; Pieniazek SN; Maloney DP; Zewinski J; O'Connell J; Banks M
    J Biomol Screen; 2015 Jun; 20(5):577-87. PubMed ID: 25722344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data.
    Paricharak S; IJzerman AP; Bender A; Nigsch F
    ACS Chem Biol; 2016 May; 11(5):1255-64. PubMed ID: 26878899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTS-Corrector: software for the statistical analysis and correction of experimental high-throughput screening data.
    Makarenkov V; Kevorkov D; Zentilli P; Gagarin A; Malo N; Nadon R
    Bioinformatics; 2006 Jun; 22(11):1408-9. PubMed ID: 16595559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARQiv-HTS, a versatile whole-organism screening platform enabling in vivo drug discovery at high-throughput rates.
    White DT; Eroglu AU; Wang G; Zhang L; Sengupta S; Ding D; Rajpurohit SK; Walker SL; Ji H; Qian J; Mumm JS
    Nat Protoc; 2016 Dec; 11(12):2432-2453. PubMed ID: 27831568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated in vitro-in silico screening strategy for the discovery of antibacterial compounds.
    Nybond S; Ghemtio L; Nawrot DA; Karp M; Xhaard H; Tammela P
    Assay Drug Dev Technol; 2015; 13(1):25-33. PubMed ID: 25710544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of microscopy and Alamar blue reduction in a larval based assay for schistosome drug screening.
    Mansour NR; Bickle QD
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e795. PubMed ID: 20706580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of small molecule libraries for NMR screening and other applications in drug discovery.
    Jacoby E; Davies J; Blommers MJ
    Curr Top Med Chem; 2003; 3(1):11-23. PubMed ID: 12570776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening Pools of Compounds against Multiple Endogenously Expressed Targets in a Chemoproteomics Binding Assay.
    Salzer E; Nixon E; Drewes G; Reinhard F; Bergamini G; Rau C
    J Lab Autom; 2016 Feb; 21(1):133-42. PubMed ID: 26169024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.